Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer.
El Ouagari, Khalid
Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer. [electronic resource] - Breast cancer research and treatment Jan 2007 - 37-49 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
0167-6806
10.1007/s10549-006-9262-4 doi
Antineoplastic Agents--economics
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant--economics
Cost-Benefit Analysis
Female
Humans
Letrozole
Middle Aged
Nitriles--economics
Quality-Adjusted Life Years
Tamoxifen--therapeutic use
Treatment Outcome
Triazoles--economics
Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer. [electronic resource] - Breast cancer research and treatment Jan 2007 - 37-49 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
0167-6806
10.1007/s10549-006-9262-4 doi
Antineoplastic Agents--economics
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant--economics
Cost-Benefit Analysis
Female
Humans
Letrozole
Middle Aged
Nitriles--economics
Quality-Adjusted Life Years
Tamoxifen--therapeutic use
Treatment Outcome
Triazoles--economics